These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23364452)

  • 1. The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice.
    Chia JS; McRae JL; Thomas HE; Fynch S; Elkerbout L; Hill P; Murray-Segal L; Robson SC; Chen JF; d'Apice AJ; Cowan PJ; Dwyer KM
    Diabetes; 2013 Jun; 62(6):2026-35. PubMed ID: 23364452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39 overexpression does not attenuate renal fibrosis in the unilateral ureteric obstructive model of chronic kidney disease.
    Roberts V; Lu B; Chia J; Cowan PJ; Dwyer KM
    Purinergic Signal; 2016 Dec; 12(4):653-660. PubMed ID: 27565966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.
    Yoshida O; Dou L; Kimura S; Yokota S; Isse K; Robson SC; Geller DA; Thomson AW
    Transpl Immunol; 2015 Mar; 32(2):76-83. PubMed ID: 25661084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
    Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
    Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.
    Pommey S; Lu B; McRae J; Stagg J; Hill P; Salvaris E; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
    Hepatology; 2013 Apr; 57(4):1597-606. PubMed ID: 22829222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
    Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
    Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Lazar Z; Müllner N; Lucattelli M; Ayata CK; Cicko S; Yegutkin GG; De Cunto G; Müller T; Meyer A; Hossfeld M; Sorichter S; Horvath I; Virchow CJ; Robson SC; Lungarella G; Idzko M
    Eur Respir J; 2016 Jan; 47(1):254-63. PubMed ID: 26541524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
    Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
    PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of purinergic signaling on renal ischemia-reperfusion injury.
    Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
    Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
    Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
    Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
    Künzli BM; Nuhn P; Enjyoji K; Banz Y; Smith RN; Csizmadia E; Schuppan D; Berberat PO; Friess H; Robson SC
    Gastroenterology; 2008 Jan; 134(1):292-305. PubMed ID: 18036594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable impact of CD39 in experimental murine colitis.
    Künzli BM; Berberat PO; Dwyer K; Deaglio S; Csizmadia E; Cowan P; d'Apice A; Moore G; Enjyoji K; Friess H; Robson SC
    Dig Dis Sci; 2011 May; 56(5):1393-403. PubMed ID: 20936356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
    Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
    Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
    Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
    Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.